TY - JOUR
T1 - Occurrence, mortality, and economic burden of brain disorders in Denmark, 2015–2021
T2 - a population-based cohort study
AU - Fuglsang, Cecilia Hvitfeldt
AU - Rasmussen, Thomas Bøjer
AU - Rudolfsen, Jan Håkon
AU - Olsen, Jens
AU - Skipper, Niels
AU - Ulrichsen, Sinna Pilgaard
AU - Sørensen, Henrik Toft
AU - Christiansen, Christian Fynbo
N1 - Publisher Copyright:
© 2024 The Author(s)
PY - 2025/3
Y1 - 2025/3
N2 - Background: Brain disorders (neurological and mental disorders) are common and burdensome diseases. We examined occurrence, mortality, and economic burden of brain disorders in Denmark from 2015 to 2021. Methods: We conducted a nationwide population-based cohort study using individual-level registry data. We computed the prevalence of any brain disorder and 25 individual brain disorders for each year from 2015 to 2021 and incidence for 2011–2015 and 2016–2021. We computed one-year hazard ratios (HRs) for all-cause mortality by comparing individuals with brain disorders to matched controls without and calculated attributable direct and indirect costs (i.e., economic burden) of brain disorders. Findings: The prevalence of any brain disorder in Denmark was 1,893,318/5,705,540 = 33.2% in 2015, increasing to 2,059,852/5,856,666 = 35.2% in 2021. The most prevalent conditions were depression (793,419/5,856,666 = 13.5% in 2021), sleep disorders (788,209/5,856,666 = 13.5% in 2021), and headache (461,353/5,856,666 = 7.9% in 2021). The incidence rate of any brain disorder was 1792 and 1634 per 100,000 person-years in 2011–2015 and 2016–2021, respectively. The one-year HR of mortality for any brain disorder was 5.5 (95% confidence interval [CI]: 5.4; 5.6) for 2011–2015 and 5.3 (95% CI: 5.2; 5.3) for 2016–2021. The total attributable direct costs for individuals with any brain disorder were €7.5 billion in both 2015 and 2021. Total indirect costs increased from €17.7 billion in 2015 to €23.2 billion in 2021. Interpretation: Brain disorders remain common, with a fivefold higher one-year mortality compared to persons without brain disorders. While total direct costs were similar in 2015 and 2021, total indirect costs increased over this period. Funding: The Lundbeck Foundation (R433-2023-1140).
AB - Background: Brain disorders (neurological and mental disorders) are common and burdensome diseases. We examined occurrence, mortality, and economic burden of brain disorders in Denmark from 2015 to 2021. Methods: We conducted a nationwide population-based cohort study using individual-level registry data. We computed the prevalence of any brain disorder and 25 individual brain disorders for each year from 2015 to 2021 and incidence for 2011–2015 and 2016–2021. We computed one-year hazard ratios (HRs) for all-cause mortality by comparing individuals with brain disorders to matched controls without and calculated attributable direct and indirect costs (i.e., economic burden) of brain disorders. Findings: The prevalence of any brain disorder in Denmark was 1,893,318/5,705,540 = 33.2% in 2015, increasing to 2,059,852/5,856,666 = 35.2% in 2021. The most prevalent conditions were depression (793,419/5,856,666 = 13.5% in 2021), sleep disorders (788,209/5,856,666 = 13.5% in 2021), and headache (461,353/5,856,666 = 7.9% in 2021). The incidence rate of any brain disorder was 1792 and 1634 per 100,000 person-years in 2011–2015 and 2016–2021, respectively. The one-year HR of mortality for any brain disorder was 5.5 (95% confidence interval [CI]: 5.4; 5.6) for 2011–2015 and 5.3 (95% CI: 5.2; 5.3) for 2016–2021. The total attributable direct costs for individuals with any brain disorder were €7.5 billion in both 2015 and 2021. Total indirect costs increased from €17.7 billion in 2015 to €23.2 billion in 2021. Interpretation: Brain disorders remain common, with a fivefold higher one-year mortality compared to persons without brain disorders. While total direct costs were similar in 2015 and 2021, total indirect costs increased over this period. Funding: The Lundbeck Foundation (R433-2023-1140).
KW - Epidemiology
KW - Health economics
KW - Neurology
KW - Psychiatry
UR - http://www.scopus.com/inward/record.url?scp=85212325257&partnerID=8YFLogxK
U2 - 10.1016/j.lanepe.2024.101189
DO - 10.1016/j.lanepe.2024.101189
M3 - Journal article
C2 - 39810989
AN - SCOPUS:85212325257
SN - 2666-7762
VL - 50
JO - The Lancet Regional Health - Europe
JF - The Lancet Regional Health - Europe
M1 - 101189
ER -